Assays for Enhanced Activity of Low Efficacy Partial Agonists at the D2dopamine Receptor

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0706866
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Nicotine Receptor Partial Agonists for Smoking Cessation

2007English

Possibilities of Partial D3-Receptor Agonists Usage in Addictive Pathology

Effective Pharmacotherapy
2020English

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Estimating Binding Affinities of the Nicotinic Receptor for Low-Efficacy Ligands Using Mixtures of Agonists and Two-Dimensional Concentration–Response Relationships

Journal of General Physiology
Physiology
2006English

14β-O-Cinnamoylnaltrexone and Related Dihydrocodeinones Are Mu Opioid Receptor Partial Agonists With Predominant Antagonist Activity

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2009English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Allosteric Modulation of the Glycine Receptor Activated by Agonists Differing in Efficacy

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2015English

Partial Agonists for Α4β2 Nicotinic Receptors Stimulate Dopaminergic Neuron Firing With Relatively Enhanced Maximal Effects

British Journal of Pharmacology
Pharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy